William Y Kim


Affiliation: University of North Carolina
Country: USA


  1. Saito R, Smith C, Utsumi T, Bixby L, Kardos J, Wobker S, et al. Molecular Subtype-Specific Immunocompetent Models of High-Grade Urothelial Carcinoma Reveal Differential Neoantigen Expression and Response to Immunotherapy. Cancer Res. 2018;78:3954-3968 pubmed publisher
    ..b>Significance: This work establishes human-relevant mouse models of bladder cancer. Cancer Res; 78(14); 3954-68. ©2018 AACR. ..
  2. Leung J, Kim W. Stearoyl co-A desaturase 1 as a ccRCC therapeutic target: death by stress. Clin Cancer Res. 2013;19:3111-3 pubmed publisher
    ..Inhibition of stearoyl-coA desaturase 1 (SCD1) in ccRCC reveals antitumor activity, independently and in synergy with mTOR inhibition. SCD1 may be a potential novel therapeutic target in treating ccRCC. ..
  3. Kim W, Perera S, Zhou B, Carretero J, Yeh J, Heathcote S, et al. HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice. J Clin Invest. 2009;119:2160-70 pubmed
    ..They further suggest a possible causal relationship between HIF2alpha and prognosis in patients with NSCLC. ..